Does smoking prevent sinus surgery from making patients feel better? Over the years, evidence and expert opinion have varied on this topic. As a result, some surgeons refuse to provide endoscopic sinus surgery (ESS) for active smokers, while others will operate because they believe surgery improves quality of life.
A 78-year-old woman presented with a 10-year history of progressive dysphagia for solid foods and pills, with intermittent regurgitation of pills but not food. No aspiration or weight loss was reported. Her past medical history was significant for breast cancer, hypothyroidism and arthritis. No head and neck masses were appreciated. A modified barium swallow was obtained.
Although voice disorders in children are not new, recognition of the need to address and treat these disorders in many children is increasing.
The right way to restore a patient’s nose after cancer depends on subtle factors: The shape, the depth, and the precise location of the wound all dictate how to go about the reconstruction, according to experts at the Triological Society Combined Sections Meeting.
Hemangiomas in pediatric patients pose a special challenge because the proper way to proceed might not be clear immediately, according to panelists at the Triological Society Combined Sections Meeting.
More and more options are emerging to help patients improve their hearing, a group of aural rehabilitation panelists said on Jan. 27 at the Triological Society Combined Sections Meeting.
A new treatment algorithm for advanced otosclerosis, based on the clinical experience of Dutch investigators and supported by a literature review they conducted, suggests that the window for successful cochlear implantation (CI) in patients with severe disease is narrower than some otolaryngologists may believe .
Maintaining sinus patency after functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS) has long been an issue; as many as 23 to 47 percent of patients require revision surgery after FESS. Now, a new drug-eluting, bioabsorbable stent manufactured by Intersect (Palo Alto, Calif.) is being billed as a “breakthrough treatment [that] improves outcomes for sinus surgery,” according to a news release from the company. The device, which received pre-market approval from the U.S. Food and Drug Administration (FDA) in August, has been studied since 2008. It is currently available in Texas, New York, Philadelphia, New Jersey, Atlanta, Ohio and Kentucky.
Born in Council Bluffs, Iowa, Patrick Edgar Brookhouser, MD, grew up in Missouri Valley, Iowa, where he graduated valedictorian from the local high school. His intellect and natural curiosity earned him numerous academic awards, and he graduated from Creighton University summa cum laude and from Johns Hopkins Medical School as a member of Alpha Omega Alpha.
Oral appliances may work better than CPAP for some patients